Literature DB >> 167195

Presence of herpes simplex virus-related antigens in transformed L cells.

K C Chadha, W Munyon.   

Abstract

Antiserum prepared against herpes simplex virus type 1 (HSV-1)-infected L cells, i.e., lytic antiserum, was shown by an indirect immunofluorescence test to stain 90 percent of HSV-transformed L or HeLa cells. Immunofluorescence in these cells was always most intense in the perinuclear cytoplasmic region. Similar results were obtained with antiserum prepared against HSV-transformed L cells. These data indicate that HSV-transformed cells (both L and HeLa) express HSV-related antigens. Antiserum prepared against HSV-1-transformed L cells, i.e., transformed-cell antiserum, was found to agglutinate purified HSV type 1 virions but failed to neutralize infectivity. This suggests that HSV-1 structural antigens are expressed in HSV-1-transformed L cells. Immunodiffusion studies showed that at least two HSV-related antigens could be demonstrated with antigens from HSV-1-transformed L cells and transformed-cell antiserum. These two antigens were shown to be present in all clonal lines of HSV-1-transformed cells examined, six L cell lines and one HeLa cell line. Therefore, we conclude that transformation of cells by HSV-1, which is known to be associated with acquisition of viral thymidine kinase, must also be associated with the presence of these two antigens. We performed experiments showing that there are species of HSV-related antibody in HSV-transformed cell antiserum that could not be absorbed out with antigens from HSV-infected L cells. Antibodies present in lytic antiserum were completely removed by antigen preparations from cells lytically infected with HSV-1. Also, lytic antiserum failed to block HSV-related staining of transformed L cells in a direct immunofluorescence test. These results are compatible with one of two notions: either (i) certain genes are expressed during transformation that are not expressed during lytic infection, or (ii) these genes are expressed to a much more reduced extent during lytic infection than in transformed cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167195      PMCID: PMC354615     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

3.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

4.  Herpes simplex virus as a source of thymidine kinase for thymidine kinase-deficient mouse cells: suppression and reactivation of the viral enzyme.

Authors:  R L Davidson; S J Adelstein; M N Oxman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

5.  Electrophoresis of thymidine kinase activity synthesized by cells transformed by herpes simplex virus.

Authors:  W Munyon; R Buchsbaum; E Paoletti; J Mann; E Kraiselburd; D Davis
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

6.  Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2.

Authors:  R Duff; F Rapp
Journal:  Nat New Biol       Date:  1971-09-08

7.  Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin.

Authors:  W K Ashe; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

8.  Polysomes and protein synthesis in cells infected with a DNA virus.

Authors:  R J Sydiskis; B Roizman
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

9.  Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1.

Authors:  R Duff; F Rapp
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

10.  Transfer of thymidine kinase to thymidine kinaseless L cells by infection with ultraviolet-irradiated herpes simplex virus.

Authors:  W Munyon; E Kraiselburd; D Davis; J Mann
Journal:  J Virol       Date:  1971-06       Impact factor: 5.103

View more
  7 in total

1.  Binding to chromosomes of herpes simplex-related antigens in biochemically transformed cells.

Authors:  S Kit; M Kurchak; W Wray; D R Dubbs
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Biochemical transformation of deoxythymidine kinase-deficient mouse cells with UV-irradiated equine herpesvirus type 1.

Authors:  G P Allen; J J McGowan; G A Gentry; C C Randall
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

3.  Factors governing expression of the herpes simplex virus gene for thymidine kinase in clonal derivatives of transformed mouse L cells.

Authors:  R Buttyan; P G Spear
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

4.  Cross-reacting herpes simplex virus antigens in hamster and mouse cells transformed by ultraviolet light-inactivated herpes simplex virus type 2.

Authors:  A L Boyd
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

5.  Purification and biochemical characterization of deoxythymidine kinase of deoxythymidine kinase-deficient mouse 3T3 cells biochemically transformed by equine herpesvirus type 1.

Authors:  J J McGowan; G P Allen; G A Gentry
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

6.  Thymidine kinaseless revertants of Ltk- cells transformed by herpes simplex virus type 1 are resistant to retransformation by homologous virus.

Authors:  K C Chadha; W H Munyon; R G Hughes
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

7.  Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus.

Authors:  J M Leiden; R Buttyan; P G Spear
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.